USPTO serial 79975373
MABXIENCE FROM LAB TO LIFE
Reviewed by CopyMark Law Group
Reg. 5472347Status 709
- Filing date
- Status date
- Registration date
- May 22, 2018
- Examiner
- FALK, JONATHAN ROBERT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MABXIENCE FROM LAB TO LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
E-28050 MADRID (MADRID), ES
E-28050 MADRID (MADRID), ES
E-28050 MADRID (MADRID), ES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vivian Ortiz-Ponce
VIVIAN ORTIZ-PONCE MARCAS ESTADOS UNIDOSPO BOX 9024163SAN JUAN, PR 00902-4163UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, pharmaceutical preparations for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, genitourinary disorders, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal system, diseases of the respiratory system, circulatory system, circulatory diseases, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, treatment of the liver, cholesterol, blood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments, and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, packaged meals, nutritional food bars, candy, dips, sauces and food supplements in pill, powder capsule, beverage form, effervescent tablet and liquid form | SECTION 71 - CANCELLED | — |
| 042 | Chemical, biological and pharmaceutical research services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MABXIENCE RESEARCH, S.L.
- Other trademarks owned by MABXIENCE RESEARCH, S.L.
- Other trademarks owned by MABXIENCE RESEARCH, S.L.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MABXIENCE FROM LAB TO LIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 6, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 6, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jul 30, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 28, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 19, 2018 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Sep 21, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 30, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 30, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 22, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 17, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 22, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 25, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 25, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 14, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 31, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2018 | MNDA | NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED | — |
| Jan 19, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 16, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2017 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 28, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 28, 2017 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 28, 2017 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 28, 2017 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 28, 2017 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jun 28, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 28, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 28, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 5, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 9, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 9, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 6, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 3, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 1, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 24, 2016 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |